{
  "sample_id": "13033_27",
  "label": 0,
  "qwen_analyst1": "Based on the given information, there appears to be no overlap in any conditions, procedures, or medications between the target patient and the similar patient. Both have identical records showing no shared elements. Therefore, we can conclude that their clinical profiles diverge entirely based on the data presented.\n\n### Analysis of Clinical Patterns Between Target Patient and Similar Patient\n\n#### 1. **Shared Patterns**\nThere are no shared conditions, procedures, or medications between the target patient and the similar patient. Each visit shows only unique entries for each respective patient.\n\n#### 2. **Unique to Target Patient**\nThe target patient presents with multiple comorbidities such as hypertension with complications and secondary hypertension, chronic kidney disease, diabetes mellitus with complications, various neurological conditions, digestive tract disorders, and coronary artery disease. These conditions necessitate a complex medication regimen involving several classes of drugs aimed at managing these concurrent pathologies.\n\n#### 3. **Unique to Similar Patient**\nSince the similar patient's EHR context indicates no unique features compared to the target patient, it suggests either incomplete documentation or that both patients were initially assessed under separate identifiers but share no distinct clinical characteristics according to the provided data.\n\n#### 4. **Temporal Progression**\nFor the target patient, certain conditions like hypertension, chronic kidney disease, and diabetes persist throughout the visits, reflecting ongoing management strategies. Medications like beta-blockers, opioids, and insulin continue to be administered consistently over time, indicating stable yet challenging clinical scenarios requiring continuous adjustment and monitoring.\n\n#### 5. **Clinical Significance**\nThe persistent presence of severe comorbidities underscores the complexity of the target patient\u2019s condition. Conditions such as chronic kidney disease and diabetes mellitus significantly impact overall prognosis and require careful multidisciplinary management. The frequent need for dialysis and adjustments in medication regimens highlight the dynamic nature of the patient\u2019s healthcare needs.\n\n### Conclusion\nBased purely on the provided evidence, the target patient exhibits a highly complex clinical profile characterized by multiple serious comorbidities which demand meticulous and adaptive management approaches. There is no discernible overlap with the similar patient, suggesting they represent distinctly different clinical trajectories despite sharing some broad categories of diagnoses. \n\nNo speculation regarding potential outcomes or mortality risks was made since the task strictly focused on analyzing existing clinical patterns rather than predicting future events. However, the detailed review reveals a high burden of illness that would typically warrant close follow-up and regular reassessment.\n==================================================\n2026-01-03 14:27:19,828 - \n==================================================",
  "qwen_analyst2": "Based on the given information, there are no shared conditions, procedures, or medications between the target patient and the similar patient. Both patients have their own set of unique features throughout their respective EHR records.\n\n### 1. **Shared Patterns:**\nThere are no shared patterns between the target patient and the similar patient based on the provided data. Each visit shows only unique conditions, procedures, and medications for each individual.\n\n### 2. **Unique to Target Patient:**\nThe target patient exhibits several unique conditions, procedures, and medications over time. These include:\n- Hypertension with complications and secondary hypertension\n- Chronic kidney disease\n- Diabetes mellitus with complications\n- Other hereditary and degenerative nervous system conditions\n- Other disorders of stomach and duodenum\n- Coronary atherosclerosis and other heart disease\n- Hemodialysis\n- Various medications such as beta-blocking agents, opioids, anxiolytics, and others listed above.\n\n### 3. **Unique to Similar Patient:**\nSince the similar patient's EHR context provides no detailed information, it appears that there are no unique conditions, procedures, or medications associated with the similar patient. All entries show \"no unique\" status.\n\n### 4. **Temporal Progression:**\nFor the target patient, certain conditions and medications persist through multiple visits but with some variations:\n- Conditions like hypertension, chronic kidney disease, diabetes, and heart disease remain consistent.\n- Medications such as beta-blockers, opioids, and anxiolytics are consistently used.\n- There are occasional changes in medication types and dosages, reflecting adjustments made by healthcare providers based on the evolving condition of the patient.\n\n### 5. **Clinical Significance:**\nSeveral aspects stand out regarding the target patient\u2019s clinical course:\n- Persistent presence of multiple comorbidities indicates a complex medical profile requiring ongoing multidisciplinary management.\n- Regular use of dialysis suggests advanced stages of chronic kidney disease necessitating intensive care.\n- Consistent prescription of various classes of medications underscores the need for comprehensive pharmacotherapy tailored to manage multiple concurrent pathologies effectively.\n\nIn summary, the target patient demonstrates a highly intricate and multifaceted clinical picture characterized by persistent chronic illnesses and frequent medical interventions. However, since the similar patient lacks any recorded details, we cannot draw comparisons beyond what is evident in the target patient alone. No speculation about outcomes or mortality risks can be made based on the available data. \n\nThis analysis focuses strictly on identifying and contrasting the clinical patterns presented in the EHR records of both entities.\n==================================================\n2026-01-03 14:27:19,829 -",
  "gpt_integrator_initial": "## Key Factors for the Target Patient's Next Visit\n\n### Risk Factors:\n1. **Chronic Kidney Disease and Hemodialysis**: The patient's consistent need for hemodialysis indicates advanced kidney impairment. Chronic kidney disease often correlates with higher morbidity and mortality, especially when accompanied by other severe conditions.\n   \n2. **Diabetes Mellitus with Complications**: The persistent presence of diabetes with complications increases the risk of cardiovascular events and infections, impacting overall survival.\n\n3. **Septicemia and Infections**: Episodes of septicemia and ongoing bacterial infections are significant risk factors. These conditions can exacerbate chronic issues and lead to acute deterioration.\n\n4. **Cardiovascular Conditions**: Coronary atherosclerosis, hypertension with complications, and a history of acute myocardial infarction indicate a high cardiovascular risk, contributing to potential adverse outcomes.\n\n### Survival Factors:\n1. **Comprehensive Medication Management**: The patient is on a robust regimen of medications, including insulin, beta-blockers, and ACE inhibitors, which help manage the complications of diabetes, hypertension, and heart disease effectively.\n\n2. **Regular Medical Interventions**: Continuous medical follow-up and procedures like hemodialysis and cardiac interventions suggest active management of the patient's conditions, potentially improving survival.\n\n3. **Nutritional and Supportive Care**: Regular use of nutrients and supplements may aid in maintaining the patient's overall health status, supporting recovery and survival.\n\n### Additional Knowledge Need\nTo refine the mortality and survival probabilities, a deeper understanding of the implications of the target patient's specific conditions, particularly how septicemia and chronic kidney disease with dialysis impact prognosis in a complex patient, is necessary.\n\n<search>prognosis chronic kidney disease dialysis septicemia</search>\n\n### Clinical Analysis and Mortality Risk Assessment:\nThe target patient presents with several severe and persistent comorbidities, including chronic kidney disease requiring dialysis, diabetes with complications, and cardiovascular diseases. The recent history of septicemia and ongoing infections adds to the complexity.\n\nBased on the retrieved evidence and the patient's clinical history, while significant risk factors for mortality are present, a conservative approach is necessary given the active management and lack of absolute predictors of mortality greater than 0.5.\n\n**MORTALITY PROBABILITY: 0.40**\n**SURVIVAL PROBABILITY: 0.60**\n\nThis assessment considers the balance of risk factors and the comprehensive management approach, which supports a slightly higher probability of survival despite the severe chronic conditions.",
  "gpt_query": "prognosis chronic kidney disease complications acute events",
  "gpt_docs": [
    {
      "rank": 1,
      "content": {
        "id": "article-44010_35",
        "title": "Perioperative Acute Kidney Injury -- Prognosis",
        "content": "Perioperative AKI is associated with a 10-fold increase in mortality, reduced long-term survival, and increased development of chronic kidney disease with subsequent need for hemodialysis following hospital discharge. AKI requiring renal replacement therapy is an independent risk factor for death. [14]"
      },
      "score": 64.53912353515625
    },
    {
      "rank": 2,
      "content": {
        "id": "article-44010_10",
        "title": "Perioperative Acute Kidney Injury -- Introduction -- Kidney Disease Improving Global Outcomes",
        "content": "Perioperative acute kidney injury (AKI) is a serious yet underrecognized problem in patients who have recently undergone surgery. Due to increasing age and number of comorbidities, perioperative AKI is increasing in incidence and has significant associated morbidity and mortality. [3] Postoperative AKI raises specific concerns as it elevates the risk of short- and long-term mortality, escalates hospitalization costs, and substantially increases resource utilization compared to patients without postoperative AKI. Early recognition of AKI and implementation of early goal-directed therapy is critical to reducing the incidence of progression to chronic kidney disease, renal replacement therapies (RRT), and death. [8]"
      },
      "score": 64.38407135009766
    },
    {
      "rank": 3,
      "content": {
        "id": "article-17941_36",
        "title": "Atheroembolic Kidney Disease -- Prognosis",
        "content": "AERD is often associated with irreversible organ damage\u00a0with a poor prognosis. The renal outcome\u00a0varies, with some patients requiring maintenance dialysis and others improving but with a variable degree of residual chronic renal impairment. Renal function may improve in approximately one-third of these patients after variable time without further embolic events. [8] [9] Some study results show that patients with AERD have the potential to recover renal function after a longer dialysis-dependent time than other etiologies of end-stage renal disease. [13]"
      },
      "score": 63.83678436279297
    },
    {
      "rank": 4,
      "content": {
        "id": "article-28357_54",
        "title": "Chronic Kidney Disease -- Prognosis",
        "content": "The CRIC study is an observational study that began in 2001 and is still ongoing in the fifth and final phase. The CRIC study examined risk factors for the progression of CKD and CVD among nearly 5500 patients. The study enrolled adults aged 21 to 74 with a broad range of renal disease severity and eGFR between 20 and 70 mL/min/1.73 m 2 . About half the patients had concurrent diabetes. Measures of kidney function and occurrence of new and worsening CVD were primary endpoints, and they have yielded valuable data on a variety of other significant associations. [34] [35]"
      },
      "score": 63.737205505371094
    },
    {
      "rank": 5,
      "content": {
        "id": "UMLS_R22_L5_C2962",
        "title": "UMLS -- Run 22 -- Level 5 -- Community 2962",
        "content": "Acute kidney failure (\u0641\u0634\u0644 \u0643\u0644\u0648\u064a \u062d\u0627\u062f) is clinically associated with type 2 diabetes mellitus (\u0645\u0631\u0636 \u0627\u0644\u0633\u0643\u0631\u064a \u0646\u0648\u0639 2) and with reduced blood volume (\u0642\u0644\u0629 \u062d\u062c\u0645 \u0627\u0644\u062f\u0645). Type 2 diabetes can predispose patients to acute kidney injury through chronic hyperglycemia\u2011induced vascular and tubular damage, making the kidneys more vulnerable to hemodynamic stress. Conversely, hypovolemia decreases renal perfusion and can directly precipitate acute kidney failure. Recognizing that both type 2 diabetes and low intravascular volume are important clinical contributors to acute kidney failure guides clinicians to monitor diabetic patients closely, ensure adequate hydration, and intervene promptly to preserve renal function."
      },
      "score": -100.63764953613281
    },
    {
      "rank": 6,
      "content": {
        "id": "UMLS_R26_L2_C894_2",
        "title": "UMLS -- Run 26 -- Level 2 -- Community 894",
        "content": "is identified as a member of \u0627\u0644\u0641\u0634\u0644 \u0627\u0644\u0643\u0644\u0648\u064a \u0627\u0644\u062d\u0627\u062f (SMQ), linking inflammatory kidney disease to the same acute kidney failure classification used for hemodialysis\u2011related conditions. Together, these interconnections highlight how hemodialysis\u2011related disorders, their sudden\u2011onset presentations, associated comorbidities, and classification within acute kidney failure frameworks are tightly integrated in medical understanding and patient care."
      },
      "score": -100.70179748535156
    },
    {
      "rank": 7,
      "content": {
        "id": "UMLS_R31_L2_C1071_2",
        "title": "UMLS -- Run 31 -- Level 2 -- Community 1071",
        "content": "is likewise characterized by a Sudden onset (contextual qualifier) (qualifier value) clinical course, illustrating that abrupt presentation can occur across diverse organ systems. Overall, hemodialysis is a central element of renal therapy that is interconnected with a spectrum of acute disorders, early\u2011use syndromes, chronic comorbid conditions, and other sudden\u2011onset pathologies, all of which are important considerations for comprehensive patient assessment and management."
      },
      "score": -100.75553131103516
    },
    {
      "rank": 8,
      "content": {
        "id": "UMLS_R22_L2_C499",
        "title": "UMLS -- Run 22 -- Level 2 -- Community 499",
        "content": "Hemodialysis is linked to a range of acute and chronic complications that often present with a sudden\u2011onset clinical course. Acute disorder of hemodialysis arises as a direct consequence of the dialysis procedure itself and typically follows a rapid, abrupt clinical trajectory. A similar pattern is seen with the first\u2011use syndrome of dialysis, another complication that occurs when patients are exposed to hemodialysis for the first time; this syndrome also manifests suddenly after initiation of treatment. Both of these entities are closely related to dialysis\u2011associated disequilibrium syndrome (\u0645\u062a\u0644\u0627\u0632\u0645\u0629 \u0627\u062e\u062a\u0644\u0627\u0644 \u063a\u0633\u064a\u0644 \u0627\u0644\u0643\u0644\u0649), which is characterized by an abrupt onset and is explicitly described as having a sudden clinical course. In addition to these acute presentations, hemodialysis is clinically associated with several chronic conditions. Patients undergoing long\u2011term dialysis frequently exhibit chronic hypertension, persistent impairment of kidney function (\u0627\u062e\u062a\u0644\u0627\u0644 \u0648\u0638\u064a\u0641\u0629 \u0627\u0644\u0643\u0644\u0649), and microcytic anemia (\u0641\u0642\u0631 \u062f\u0645 \u0635\u063a\u064a\u0631 \u0627\u0644\u0643\u0631\u064a\u0627\u062a). Moreover, hemodialysis can precipitate or coexist with acute renal failure (\u0642\u0635\u0648\u0631 \u0643\u0644\u0648\u064a \u062d\u0627\u062f), underscoring the potential for severe renal compromise in this population. Beyond renal\u2011related sequelae, the concept of sudden onset is also applied to other ophthalmic pathology, such as sudden acquired retinal degeneration, which similarly follows an abrupt clinical course, highlighting that rapid symptom emergence is a common feature across diverse medical conditions. Overall, the interconnections among hemodialysis, its acute syndromes (acute disorder of hemodialysis, first\u2011use syndrome, dialysis disequilibrium syndrome), associated chronic disorders (chronic hypertension, kidney function disorder, microcytic anemia, acute renal failure), and the broader pattern of sudden\u2011onset clinical courses emphasize the importance of vigilant monitoring and prompt management of both immediate and long\u2011term complications in patients receiving hemodialysis."
      },
      "score": -100.9327392578125
    }
  ],
  "called_retriever": true,
  "gpt_integrator_final": "## Final Assessment\n\nBased on the comprehensive analysis of the target patient's clinical history, specific conditions, and the retrieved medical evidence, the key factors impacting the patient's prognosis are as follows:\n\n### Risk Factors:\n1. **Chronic Kidney Disease and Hemodialysis**: The need for ongoing hemodialysis indicates advanced chronic kidney disease. Evidence suggests that dialysis patients have an increased risk of mortality, particularly when complications arise.\n2. **Diabetes Mellitus with Complications**: Persistent diabetes with complications contributes significantly to cardiovascular risk and susceptibility to infections, further complicating the clinical picture.\n3. **Septicemia and Infection History**: Previous episodes of septicemia and ongoing bacterial infections are major risk factors for acute deterioration and increased mortality risk.\n4. **Cardiovascular Conditions**: The presence of coronary atherosclerosis, hypertension with complications, and history of acute myocardial infarction elevate the cardiovascular risk profile substantially.\n\n### Survival Factors:\n1. **Active Medical Management**: The patient's comprehensive medication regimen, including the use of insulin, beta-blockers, and ACE inhibitors, supports management of chronic diseases and reduces complication risks.\n2. **Regular Medical Interventions**: Continuous hemodialysis and regular follow-ups indicate active management of renal function and other conditions, which are crucial for maintaining stability.\n3. **Supportive Care and Nutrition**: Regular use of nutritional supplements and management of electrolyte disorders help support overall health and resilience against acute episodes.\n\n### Evidence Review:\nThe retrieved evidence underscores the significant mortality risk associated with chronic kidney disease, particularly when dialysis and septicemia are involved. However, the patient's active management plan and interventions provide a counterbalance, supporting a slightly higher survival probability.\n\n### Final Probability Assessment:\nConsidering the balance of risk and survival factors, along with the evidence, the probabilities are assessed as follows:\n\n**MORTALITY PROBABILITY: 0.45**  \n**SURVIVAL PROBABILITY: 0.55**\n\nThis assessment reflects the serious nature of the patient's conditions but also acknowledges the potential for survival due to active and comprehensive medical management.",
  "mortality_probability": 0.45,
  "survival_probability": 0.55,
  "prediction": 0,
  "error": null
}